Stay updated with breaking news from Markc Schneyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) was the recipient of a significant growth in short interest in the month of April. As of April 30th, there was short interest totalling 12,030,000 shares, a growth of 7.8% from the April 15th total of 11,160,000 shares. Based on an average daily trading volume, of 1,810,000 […]
Cantor Fitzgerald restated their overweight rating on shares of ACADIA Pharmaceuticals (NASDAQ:ACAD – Free Report) in a report released on Tuesday morning, Benzinga reports. Cantor Fitzgerald currently has a $37.00 price objective on the biopharmaceutical company’s stock. A number of other equities research analysts have also recently commented on ACAD. Royal Bank of Canada decreased […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) shares hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $16.60 and last traded at $16.74, with a volume of 1475997 shares traded. The stock had previously closed at $16.99. Wall Street Analyst Weigh In ACAD has been the […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) was the recipient of a large increase in short interest in March. As of March 31st, there was short interest totalling 11,200,000 shares, an increase of 5.4% from the March 15th total of 10,630,000 shares. Based on an average daily volume of 1,830,000 shares, the days-to-cover ratio […]
China Universal Asset Management Co. Ltd. increased its stake in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) by 351.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 18,985 shares of the biopharmaceutical company’s stock after purchasing an additional 14,783 shares during the […]